PT-141

PT-141, also known as Bremelanotide, is a research-grade synthetic cyclic heptapeptide derived as a metabolite of Melanotan II. It functions as a non-selective melanocortin receptor agonist with particular affinity for MC3R and MC4R subtypes. Unlike vasoactive compounds that act peripherally, PT-141 operates centrally via the nervous system, making it a unique reference compound for studying neuroendocrine and central arousal pathways at the receptor level.

Available in 10mg vials

RESEARCH APPLICATIONS INCLUDE:

• Melanocortin receptor (MC1R–MC5R) agonism and binding kinetics studies
• Central nervous system arousal signalling research models
• Neuroendocrine function and hypothalamic pathway investigation
• Peptide-mediated mood and behaviour modulation mechanism studies
• Comparative research vs PDE5 inhibitors and peripheral vasoactive compounds
• α-MSH analogue and pigmentation pathway research

PRODUCT SPECIFICATIONS:

• Form: Lyophilised powder
• Purity: ≥99% 
• Storage: −20°C, protected from light and moisture
• Available strength: 10mg

⚠ For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. Must be handled by qualified professionals in a suitable laboratory environment. Not evaluated by the MHRA or any regulatory authority for therapeutic use